Approaches Used by Drug Manufacturers to Develop Vaccine Against Coronavirus
The world continues to experience the effects of the coronavirus outbreak, and the drug manufacturing companies are working day and night in efforts to come up with a vaccine that will keep people from contracting the disease. In order to accelerate the process, the majority of these organizations are taking new ways of coming up with the vaccine which are not been previously applied. Let us look at how the pharmaceutical companies are developing coronavirus vaccines.
Accelerated Development Processes
One of the primary ways that pharma companies are attempting to move quickly on coronavirus vaccine development is by leveraging existing platforms and processes. Many of these organizations have already begun clinical trials on existing vaccines, such as those designed for influenza and other coronaviruses. By using these platforms, they can potentially reduce the amount of time it takes to bring a safe and effective vaccine to market.
In addition, many pharma organizations are utilizing newer technologies in their efforts, including artificial intelligence (AI) systems that can help identify potential drugs or treatments faster than traditional methods. There are also new ways of treatment being investigated using the methods of gene therapy where genetic material is used to change the functioning of cells and mRNA vaccines that use RNA molecules to train your immune system to fight viruses.
Collaborative Efforts
To ensure that there is rapid development of an effective vaccine, most of these entities are collaborating with government agencies and nonprofit organizations. For example, Pfizer has entered into a partnership with BioNTech SE of Germany for conducting its research; Johnson & Johnson has entered into a partnership with Janssen Pharmaceuticals; Moderna has partnered with the National Institutes of Health; AstraZeneca has entered into a partnership with Oxford University; and Novavax has partnered with Emergent BioSolutions. All of these collaborations provide the organizations with the opportunity to collaborate and use their resources for the development of a successful vaccine quickly.
It is clear that the development of a safe and effective coronavirus vaccine is now at its peak, and pharmaceutical companies are doing their best to make this process quicker. By using already established processes and technologies, such as AI systems and gene therapy techniques, along with the help of partner organizations, they are trying to develop the vaccine solution in order to be successful as soon as possible. Hopefully, we will get some of these vaccines very soon!